FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS

Authors

  • Sridevi Gowripattapu Department of Pharmaceutics, Aditya Pharmacy College, Aditya Nagar, ADB road, Surampalem-533437,
  • S. Madhavi Latha Department of Pharmaceutics, Aditya Pharmacy College, Aditya Nagar, ADB road, Surampalem-533437, Andhra Pradesh, India

Abstract

The objective of the present investigation was to design suitable sustained release tablet formulation of Nateglinide by using different polymers such as hydroxy propyl methyl cellulose K15M, xanthan gum, guar gum as release rate retarding polymers. The tablets were prepared by direct compression technique. Nateglinide is used as anti diabetic drug. The objective of the treatment is to achieve hypoglycemia, by using an ideal dosage regimen. The sustained release formulation provides extend duration of action in therapeutic range without reaching toxic levels as in the case of conventional dosage forms. The real formulation trails are carried from F1 to F9 in which Drug: Polymer ratio was set as 1:9 respectively. The prepared formulations F1 to F9 were evaluated for pre and post compression characteristics, along with the in vitro dissolution Studies. It was found that the release of drug from F1, F2, and F3 gave the better release than other formulations. In these three formulations F2 showing highest release following first order kinetics. From the Higuchi plot good correlation coefficient was observed showing diffusion mechanism. From the peppas plot it was observed that the release model was non fickian anomalous. The release rate was decreased as polymer concentration increased so it shows that increase in diffusion length of polymer decreases the release rate.

Keywords:

Nateglinide, sustained release tablets, Hydroxy propyl methyl cellulose K15M, Xanthan gum, Guar gum

DOI

https://doi.org/10.25004/IJPSDR.2016.080102

References

1. www.drugbank.ca/drugs
2. wikipedia.org/wiki/Nateglinide
3. Milo Gibaldi, Donald Pferzier. Pharmacokinetics Edn 2, Vol.15 revised and expanded pp.185.
4. www.ema.europa.eu, EMEA 2004.
5. Q Li. Inter particle Vander Waals force in powder Flowability and compatibility. Int J Pharm. 2004; 280(1-2):77-93.
6. Conesa C, Saleh K, Thomas A, Guigon P, Guillot N. Characterization of Flow Properties of Powder Coatings Used in the Automotive Industry. Powder and particle 2004; 22:94-106.
7. Niazi, Sarfaraz. Handbook of Pharmaceutical Manufacturing Formulations. 2004, pp. 275-276.
8. Madgulkar AR, Bhalekar MR, Warghade NS, Chavan NS. Preparation and Evaluation of Sustained release matrix tablet of Nateglinide: Effect of variables. Inventi Rapid: NDDS, 2011; 135.
9. Rajasekaran A, Murugesan S. Spectrophotometric determination of nateglinide. Indian J Pharm Sci. 2004; 66(6):806-807.
10. Prakash O, Saraf S, Rahman M, Agnihotri N, Pathak V. Formulation and Evaluation of Floating Nateglinide Tablets Using Factorial Design. Research and Reviews: Journal of Pharmaceutical Analysis 2013; 2(4):13-18.
11. Mallika S, Kshirasagar MD, Ani VS. Study on physical/chemical compatibility between drugs with various pharmaceutical excipients. Int J Pharm Sci. 2011; 3(5):173-178.

Published

01-01-2016
Statistics
Abstract Display: 689
PDF Downloads: 572
Dimension Badge

How to Cite

“FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 8, no. 1, Jan. 2016, pp. 07-12, https://doi.org/10.25004/IJPSDR.2016.080102.

Issue

Section

Research Article

How to Cite

“FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 8, no. 1, Jan. 2016, pp. 07-12, https://doi.org/10.25004/IJPSDR.2016.080102.